CIS1 Interacts with the Y532 of the Prolactin Receptor and Suppresses Prolactin-Dependent STAT5 Activation
The DOI matches its Crossref record.
Abstract
Prolactin (PRL) interacts with a single-chain prolactin-specific receptor of the cytokine receptor superfamily. PRL triggers the activation of JAK2 kinase, which phosphorylates the PRL receptor itself, and of STAT5, a member of the family of signal transducers and activators of transcription (STAT). We have shown that the STAT5-dependent immediate early gene, CIS1 (Cytokine-Inducible SH2 domain-containing protein-1), suppresses PRL-induced STAT5 activation in vitro as well as in transgenic mice. To facilitate the study of the interactions between CIS1 and the PRL receptor, we have developed the yeast tri-hybrid system, a modification of the yeast two-hybrid system. We expressed CIS1 fused to the DNA-binding domain and PRL receptor cytoplasmic domain fused to the transcription activation domain in the presence or absence of the tyrosine kinase domain of JAK2 in yeast. CIS1 bound to the PRL receptor cytoplasmic domain in a JAK2-dependent manner. Moreover, we determined that the phosphorylated Y532 of the murine PRL receptor is the binding site for CIS1. Interestingly, Y532 has been shown to be unnecessary for STAT5 activation, although CIS1 overexpression suppressed PRL-induced STAT5 activation. These data suggest that the suppression of STAT5 activation by CIS1 is not due to a simple competition with STAT5 but rather to a modification of the receptor by CIS1 binding.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [67]
Citations
Cites
Still being checked.
Cited by
SOCS regulation of the JAK/STAT signalling pathway
Croker, B. A., Kiu, H., & Nicholson, S. E. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.010 · Cited by 611
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
Negative Regulation of Cytokine Signaling in Immunity
Yoshimura, A., Ito, M., Chikuma, S., Akanuma, T., & Nakatsukasa, H. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028571 · Cited by 196
Suppression of cytokine signaling: The SOCS perspective
Linossi, E. M., Babon, J. J., Hilton, D. J., & Nicholson, S. E. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.005 · Cited by 192
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance
Palmer, D. C., Guittard, G. C., Franco, Z., Crompton, J. G., Eil, R. L., Patel, S. J., Ji, Y., Van Panhuys, N., Klebanoff, C. A., Sukumar, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150304 · Cited by 200
The transcriptional response of the islet to pregnancy in mice
Rieck, S., White, P., Schug, J., Fox, A. J., Smirnova, O., Gao, N., Gupta, R. K., Wang, Z. V., Scherer, P. E., Keller, M. P., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0144 · Cited by 160
Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy
Chikuma, S., Kanamori, M., Mise‐Omata, S., & Yoshimura, A. (2017) · Cancer Science · doi:10.1111/cas.13194 · Cited by 112
Self-citationConvergent Evolution of Slick Coat in Cattle through Truncation Mutations in the Prolactin Receptor
Porto-Neto, L. R., Bickhart, D. M., Landaeta‐Hernández, A. J., Utsunomiya, Y. T., Pagán, M., Jiménez, E., Hansen, P. J., Dikmen, S., Schroeder, S., Kim, E.-S., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00057 · Cited by 108
Fleenor, D., Arumugam, R., & Freemark, M. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093667 · Cited by 80
Targeting oncogenic transcription factors: therapeutic implications of endogenous STAT inhibitors
Heppler, L. N., & Frank, D. A. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.10.004 · Cited by 74
Malignant JAK-signaling: at the interface of inflammation and malignant transformation
Perner, F., Pahl, H. L., Zeiser, R., & Heidel, F. H. (2025) · Leukemia · doi:10.1038/s41375-025-02569-8 · Cited by 77
Kedzierski, Ł., Linossi, E. M., Kolesnik, T. B., Clemens, E. B., Bird, N. L., Kile, B. T., Belz, G. T., Metcalf, D., Nicola, N. A., Kedzierska, K., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004134 · Cited by 76
The role of prolactin in central nervous system inflammation
Ramos-Martínez, E. G., Ramos-Martínez, I. E., Molina-Salinas, G., Zepeda-Ruiz, W. A., & Cerbón, M. A. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0082 · Cited by 73
A novel tilapia prolactin receptor is functionally distinct from its paralog
Fiol, D. F., Sanmarti, E., Sacchi, R., & Kültz, D. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.025601 · Cited by 64
Hirata, Y., Brems, H., Suzuki, M., Kanamori, M., Okada, M., Morita, R., Llano‐Rivas, I., Ose, T., Messiaen, L. M., Legius, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703710 · Cited by 63
Abramicheva, P. A., & Smirnova, О. V. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919040011 · Cited by 61
Anderson, S. T., Barclay, J. L., Fanning, K., Kusters, D. H. L., Waters, M. J., & Curlewis, J. D. (2005) · Endocrinology · doi:10.1210/en.2005-0905 · Cited by 52
Hanada, T., Kinjyo, I., Inagaki-Ohara, K., & Yoshimura, A. (2003) · Springer eBooks · doi:10.1007/s10254-003-0015-z · Cited by 49
Prolactin receptor in breast cancer: marker for metastatic risk
Shemanko, C. S. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0150 · Cited by 42
Negative regulation of cytokine signaling and inflammatory diseases
Inagaki-Ohara, K., Hanada, T., & Yoshimura, A. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00070-5 · Cited by 44
Uyttendaele, I., Lemmens, I. H., Verhee, A., de Smet, A.-S., Vandekerckhove, J. S., Lavens, D., Peelman, F., & Tavernier, J. H. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0541 · Cited by 52
Jiao, Y., Rieck, S., Lay, J. E. L., & Kaestner, K. H. (2013) · Diabetologia · doi:10.1007/s00125-013-3014-x · Cited by 20
Regulation of Embryonic Hematopoiesis by a Cytokine-Inducible SH2 Domain Homolog in Zebrafish
Lewis, R. S., Noor, S. M., Fraser, F. W., Sertori, R., Liongue, C., & Ward, A. C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301376 · Cited by 16
Huber, H. A., Georgia, S. K., & Finley, S. D. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111341 · Cited by 13
Abramicheva, P. A., Balakina, T. A., Morozov, I. A., Schelkunova, T. A., & Smirnova, О. V. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919100092 · Cited by 9
Jensik, P. J., & Arbogast, L. A. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.10.017 · Cited by 7
Izumchenko, E., Wolfson, M., Golemis, E. A., & Serebriiskii, I. G. (2007) · Methods in microbiology · doi:10.1016/s0580-9517(06)36006-0 · Cited by 4
STAT/SOCS Family Members in Inflammation and Diseases
Yoshimura, A., Kinjyo, I., Inagaki‐Ohara, K., & Hanada, T. (2003) · Springer eBooks · doi:10.1007/978-94-017-3000-6_34 · Cited by 1
SOCS Proteins and Cytokine Signalling: The many Faces of the SOCS Box
Piessevaux, J. (2008) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
Faculty Opinions recommendation of Negative regulation of cytokine signaling in immunity.
Weiss, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727818654.793577762
Effet pléiotrope de la mutation R96C dans le gène SOCS2 chez la brebis laitière
Oget, C. (2019) · theses.fr (ABES) · doi:10.70675/eb729d82z5b2fz44a4z8462z6fde7b3822db
Metadata
- Authors
- Endo, T.
- Affiliations
- Kurume University (JP)
- Corresponding author
- Endo, T.
- Venue
- Journal of Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 133
- Issue
- 1
- Pages
- 109-113
- ISSN
- 0021-924X (ISSN-L)
- OpenAlex
- W2048915739
- Cited by
- 31
- References
- 0
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 2
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- prolactin receptor, STAT5 activation, prolactin signaling, JAK2, receptor tyrosine phosphorylation, cytokine receptor superfamily, transcriptional repression, transgenic mice
- MeSH terms
- Animals, Binding Sites, Cell Line, DNA-Binding Proteins, Enzyme Activation, Milk Proteins, Phosphorylation, Prolactin, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Receptors, Prolactin, Tyrosine, Trans-Activators, Protein Structure, Tertiary, Receptors, Erythropoietin, Immediate-Early Proteins, src Homology Domains, Two-Hybrid System Techniques, STAT5 Transcription Factor, Suppressor of Cytokine Signaling Proteins, Mice, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.